| Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes I Gañán-Gómez, Y Wei, DT Starczynowski, S Colla, H Yang, ... Leukemia 29 (7), 1458-1469, 2015 | 239 | 2015 |
| Oncogenic functions of the transcription factor Nrf2 I Gañán-Gómez, Y Wei, H Yang, MC Boyano-Adánez, G García-Manero Free Radical Biology and Medicine 65, 750-764, 2013 | 229 | 2013 |
| Toll-like receptor alterations in myelodysplastic syndrome Y Wei, S Dimicoli, C Bueso-Ramos, R Chen, H Yang, D Neuberg, ... Leukemia 27 (9), 1832-1840, 2013 | 180 | 2013 |
| ILF2 is a regulator of RNA splicing and DNA damage response in 1q21-amplified multiple myeloma M Marchesini, Y Ogoti, E Fiorini, AA Samur, L Nezi, M D'Anca, P Storti, ... Cancer cell 32 (1), 88-100. e6, 2017 | 133 | 2017 |
| Telomere Dysfunction Drives Aberrant Hematopoietic Differentiation and Myelodysplastic Syndrome Cancer Cell 27 (5), 644-57, 2015 | 116 | 2015 |
| NPM1 mutations define a specific subgroup of MDS and MDS/MPN patients with favorable outcomes with intensive chemotherapy G Montalban-Bravo, R Kanagal-Shamanna, K Sasaki, K Patel, ... Blood advances 3 (6), 922-933, 2019 | 96 | 2019 |
| Global H3K4me3 genome mapping reveals alterations of innate immunity signaling and overexpression of JMJD3 in human myelodysplastic syndrome CD34+ cells Y Wei, R Chen, S Dimicoli, C Bueso-Ramos, D Neuberg, S Pierce, ... Leukemia 27 (11), 2177-2186, 2013 | 90 | 2013 |
| Impact of the number of mutations in survival and response outcomes to hypomethylating agents in patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative … G Montalban-Bravo, K Takahashi, K Patel, F Wang, S Xingzhi, ... Oncotarget 9 (11), 9714, 2018 | 70 | 2018 |
| Overexpression of miR-125a in Myelodysplastic Syndrome CD34+ Cells Modulates NF-κB Activation and Enhances Erythroid Differentiation Arrest I Ganan-Gomez, Y Wei, H Yang, S Pierce, C Bueso-Ramos, G Calin, ... PLoS One 9 (4), e93404, 2014 | 63 | 2014 |
| Azacitidine plus venetoclax in patients with high-risk myelodysplastic syndromes or chronic myelomonocytic leukaemia: phase 1 results of a single-centre, dose-escalation, dose … A Bazinet, F Darbaniyan, E Jabbour, G Montalban-Bravo, M Ohanian, ... The Lancet Haematology 9 (10), e756-e765, 2022 | 52 | 2022 |
| Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy I Ganan-Gomez, H Yang, F Ma, G Montalban-Bravo, N Thongon, ... Nature medicine 28 (3), 557-567, 2022 | 34 | 2022 |
| KDM6B overexpression activates innate immune signaling and impairs hematopoiesis in mice Y Wei, H Zheng, N Bao, S Jiang, CE Bueso-Ramos, J Khoury, C Class, ... Blood advances 2 (19), 2491-2504, 2018 | 32 | 2018 |
| Transcriptomic analysis implicates necroptosis in disease progression and prognosis in myelodysplastic syndromes G Montalban-Bravo, CA Class, I Ganan-Gomez, R Kanagal-Shamanna, ... Leukemia 34 (3), 872-881, 2020 | 30 | 2020 |
| Down-regulation of EZH2 expression in myelodysplastic syndromes M Cabrero, Y Wei, H Yang, I Ganan-Gomez, Z Bohannan, S Colla, ... Leukemia research 44, 1-7, 2016 | 19 | 2016 |
| Raf/MEK/ERK signaling inhibition enhances the ability of dequalinium to induce apoptosis in the human leukemic cell line K562 P Sancho, E Galeano, MC Estañ, I Ganan-Gomez, MC Boyano-Adánez, ... Experimental biology and medicine 237 (8), 933-942, 2012 | 19 | 2012 |
| Changes in mitochondrial function induced by dequalinium precede oxidative stress and apoptosis in the human prostate-cancer cell line PC-3 K Makowska, MC Estan, I Ganan-Gomez, MC Boyano-Adanez, ... Molecular Biology 48, 359-370, 2014 | 18 | 2014 |
| Hematopoiesis under telomere attrition at the single-cell resolution N Thongon, F Ma, A Santoni, M Marchesini, E Fiorini, A Rose, V Adema, ... Nature communications 12 (1), 6850, 2021 | 16 | 2021 |
| Low frequency of H3.3 mutations and upregulated DAXX expression in MDS Y Attieh, QR Geng, CD DiNardo, H Zheng, Y Jia, ZH Fang, ... Blood, The Journal of the American Society of Hematology 121 (19), 4009-4011, 2013 | 15 | 2013 |
| LILRB4 expression in chronic myelomonocytic leukemia and myelodysplastic syndrome based on response to hypomethylating agents KS Chien, CA Class, G Montalban-Bravo, Y Wei, K Sasaki, K Naqvi, ... Leukemia & lymphoma 61 (6), 1493-1499, 2020 | 14 | 2020 |
| Histone methylation in myelodysplastic syndromes Y Wei, I Gañán-Gómez, S Salazar-Dimicoli, SL McCay, G Garcia-Manero Epigenomics 3 (2), 193-205, 2011 | 12 | 2011 |
Guillermo Garcia-ManeroMD Anderson Cancer CenterVerified email at mdanderson.org
